Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
BGSF Inc
BGSF
$60.4M
| $1.48M | ﹤0.01% |
131,147
-2,118
| -2% | -$21.7K |
|
|
BCEL
2827
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $1.48M | ﹤0.01% |
69,693
+21,502
| +45% | +$380K |
|
|
PDLI
2828
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.48M | ﹤0.01% |
508,504
-1,059
| -0.2% | -$3.35K |
|
2829
Mitek Systems
MITK
$873M
| $1.48M | ﹤0.01% |
153,917
+3,432
| +2% | +$30.9K |
|
2830
Fomento Económico Mexicano
FMX
$40.2B
| $1.47M | ﹤0.01% |
23,720
+6,175
| +35% | +$393K |
|
|
HDV
2831
iShares Core High Dividend ETF
HDV
$15.2B
| $1.46M | ﹤0.01% |
90,120
-18,770
| -17% | -$303K |
|
|
CRON
2832
Cronos Group
CRON
$1.14B
| $1.46M | ﹤0.01% |
243,191
+37,641
| +18% | +$230K |
|
2833
Modine Manufacturing
MOD
$11.1B
| $1.46M | ﹤0.01% |
264,723
-34,519
| -12% | -$158K |
|
2834
Phathom Pharmaceuticals
PHAT
$760M
| $1.45M | ﹤0.01% |
44,115
+5,882
| +15% | +$226K |
|
|
BEST
2835
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $1.45M | ﹤0.01% |
16,954
+2,518
| +17% | +$259K |
|
2836
BioLife Solutions
BLFS
$1.72B
| $1.45M | ﹤0.01% |
88,794
-417
| -0.5% | -$5.75K |
|
2837
Expro Ltd
XPRO
$2.12B
| $1.45M | ﹤0.01% |
108,300
+25,996
| +32% | +$350K |
|
2838
Hurco Companies Inc
HURC
$146M
| $1.45M | ﹤0.01% |
51,733
-6,633
| -11% | -$195K |
|
2839
FS Bancorp
FSBW
$323M
| $1.45M | ﹤0.01% |
74,906
+676
| +0.9% | +$13.2K |
|
2840
Radware
RDWR
$1.23B
| $1.45M | ﹤0.01% |
61,245
+6,532
| +12% | +$150K |
|
2841
UroGen Pharma
URGN
$2.33B
| $1.44M | ﹤0.01% |
55,313
+7,117
| +15% | +$174K |
|
|
ALBO
2842
DELISTED
Albireo Pharma Inc
ALBO
| $1.44M | ﹤0.01% |
54,170
+9,426
| +21% | +$222K |
|
2843
SIGA Technologies
SIGA
$214M
| $1.43M | ﹤0.01% |
242,297
+24,971
| +11% | +$143K |
|
2844
Primis Financial Corp
FRST
$411M
| $1.43M | ﹤0.01% |
147,580
-12,802
| -8% | -$123K |
|
|
CDMO
2845
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.43M | ﹤0.01% |
217,885
+26,830
| +14% | +$150K |
|
2846
Esquire Financial Holdings
ESQ
$1.55B
| $1.43M | ﹤0.01% |
84,474
+1,541
| +2% | +$24.4K |
|
2847
Vanguard FTSE Europe ETF
VGK
$31B
| $1.43M | ﹤0.01% |
28,360
-1,555
| -5% | -$73.4K |
|
2848
AMC Entertainment Holdings
AMC
$2.23B
| $1.43M | ﹤0.01% |
33,207
-51,696
| -61% | -$2.26M |
|
2849
Precigen
PGEN
$2.21B
| $1.42M | ﹤0.01% |
285,343
-17,107
| -6% | -$58.2K |
|
2850
Red Robin
RRGB
$185M
| $1.42M | ﹤0.01% |
139,581
-8,171
| -6% | -$103K |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.